Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-08-02
2011-08-02
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S141100, C424S133100, C530S387100, C530S387300, C530S388220
Reexamination Certificate
active
07988966
ABSTRACT:
According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
REFERENCES:
patent: 2004/0131615 (2004-07-01), Shelton et al.
patent: WO-97/21732 (1997-06-01), None
patent: WO-00/73344 (2000-12-01), None
patent: WO-2004/073653 (2004-09-01), None
patent: WO-2004/096122 (2004-11-01), None
patent: WO-2005/061540 (2005-07-01), None
Cattaneo Antonino
Marinelli Sara
Pavone Flaminia
Ugolini Gabriele
Edwards Angell Palmer & & Dodge LLP
Hunter-Ensor, Esq. Melissa
Lauro, Esq. Peter C.
Lay Line Genomics S.p.A.
Lockard Jon M
LandOfFree
Method for the potentiation of opioid analgesics effects on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the potentiation of opioid analgesics effects on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the potentiation of opioid analgesics effects on... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2791170